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Background/Aims: The aim of this study was to analyze and 
propose a treatment strategy after endoscopic resection of 
superficial esophageal squamous cell carcinoma in a single 
institution. Methods: This is a retrospective review of 37 
patients who were treated by endoscopic resection during a 
6-year period. Results: The mean tumor size was 11.5±5.5 
mm (range, 3 to 31 mm). Thirty-one lesions (83.8%) were 
treated by endoscopic submucosal dissection, and six le-
sions were treated by endoscopic mucosal resection (16.2%). 
The en bloc resection rate and complete resection rate were 
91.9% and 81.8%, respectively. The tumor invasion depth 
was diagnosed as epithelial in five cases (13.5%), lamina 
propria mucosa in 12 cases (32.4%), muscularis mucosa in 
10 cases (27.0%) and submucosa in 10 cases (27.0%). The 
complication rate was 13.5% and included three cases (8.1%) 
of perforation. Ten patients who had muscularis mucosa and 
submucosa lesions received additional treatments, includ-
ing six patients who were treated with esophagectomy, three 
patients who were treated with radiotherapy and one patient 
who was treated with chemoradiotherapy. One patient with 
lamina propria lesions received radiotherapy due to a posi-
tive resection margin. The median follow-up duration was 
22 months (range, 4 to 79 months), and no recurrence or 
metastasis was noted during follow-up. Conclusions: Tai-
lored management after endoscopic treatment of superficial 
esophageal squamous cell carcinoma can offer an accept-
able oncologic outcome in early esophageal carcinoma. (Gut 
Liver 2015;9:714-719)
Key Words: Endoscopic resection; Treatment strategy; Su-
perficial esophageal squamous cell carcinoma
INTRODUCTION
Esophageal cancer represent the eighth most common malig-
nancy and the sixth leading cause of cancer mortality.1 In South 
Korea, esophageal cancer is currently eighth leading cause 
of cancer death.2 Health check-up has recently become more 
popular for screening purposes and esophagogastroduodenos-
copy (EGD) is performed biannually in individuals older than 40 
years by Korea’s National Health Insurance check-up program 
due to the high incidence of gastric cancer. So the incidence 
and detection rates of superficial esophageal squamous cell car-
cinoma (ESCC) are seemingly increasing. 
Recently endoscopic resection (ER) is recognized as a possible 
curative treatment option for ESCC confined within the mucosal 
epithelium or lamina propria mucosa.3-6 Although esophagec-
tomy has been the standard therapy for superficial ESCC, ER 
has gained widespread attention in treatment option. In ESCC 
with epithelium or lamina propria mucosa invasion, the risk 
of lymph node is minimal. In contrast, when tumor invades 
muscularis mucosa or submucosa, the risk is raised up to 10% 
to 40%.7-9 However, there are still limitations in accurate diag-
nosis of the lymph node metastasis before performing ER. And 
little information is available regarding comparative efficacy 
of endoscopic treatment in superficial esophageal cancer, and 
optimal management plan for these patients remains unknown. 
The aim of this study was to evaluate the efficacy, complication 
and long-term outcome of ER, and propose a treatment strategy 
after ER of superficial ESCC in a single institution experience. 
MATERIALS AND METHODS
1. Patients
From May 2007 to August 2013, 37 patients with superficial 
ESCC were treated by ER at Severance Hospital, Yonsei Uni-
See editorial on page 693.
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versity College of Medicine. Inclusion criteria were newly di-
agnosed ESCC confined to the mucosa or submucosa invasion, 
absence of clinical evidence of lymph node and distant organ 
metastasis with no previous treatment history. All visible lesions 
were classified according to the Japanese classification.10 The 
superficial ESCC was categorized as subtype 0 and subclassified 
as below. Type 0-I, superficial and protruding type; Type 0-II, 
superficial and flat type; Type 0-IIa, slightly elevated type; Type 
0-IIb, flat type; Type 0-IIc, slightly depressed type; Type 0-III, 
superficial and excavated type. 
Before ER, endoscopic examination with lugol solution chro-
moendoscopy, and computed tomography (CT) of chest and ab-
domen or positron emission tomography-computed tomography 
(PET-CT) were performed in all the patients. Endoscopic ultra-
sonography (EUS) was examined in most of patients to evalu-
ate depth of cancer invasion and local lymph node or adjacent 
organ metastasis (n=34). 
All resection specimens were cut into longitudinal slices 2 to 
5 mm interval. Depths of invasion, lateral and vertical resec-
tion margins, and lymphovascular invasions were evaluated. 
The depth of invasion was classified mucosa and submucosa, 
and mucosa invasion was subclassified as intraepithelial cancer, 
cancer invading the lamina propria and invading the muscu-
laris mucosa. The lymphovascular invasion and clearance of 
the basal and lateral margin were assessed by histopathologic 
examination. En bloc resection was defined as tumor resec-
tion in a single piece. Complete resection was interpreted as all 
resection margins were tumor free with en bloc resection. ER 
was conducted by endoscopic mucosal resection (EMR) consist 
of EMR using a transparent cap procedure (EMR-C), EMR with 
precutting (EMR-P) and endoscopic submucosal dissection (ESD) 
with various knives such as hook knife, IT knife-2 or dual knife.
Follow-up examinations were conducted by EGD, chromoen-
doscopy with lugol solution and biopsy specimen at 3, 6 months 
and then yearly after ER to examine for local recurrence. CT of 
chest or PET-CT was performed every year to evaluate the re-
currence and metastasis. The primary outcome of ER was deter-
mined by type of resection with complete or incomplete resec-
tion, histopathologic evaluation with accessing lymphovascular 
invasion and ER related complication. 
2. Statistical analysis
Continuous variables are expressed as the mean±standard 
deviation. The chi-square test was used to compare categorical 
variables, and the t-test was used to compare continuous vari-
ables. Survival rates were calculated using Kaplan-Meier meth-
ods and the log-rank test was performed to compare survival 
rate. The p-value of less than 0.05 was considered statistically 
significant. Statistical analysis was conducted using SPSS ver-
sion 20.0 (SPSS Inc., Chicago, IL, USA). 
RESULTS
1. Clinicopathologic features
Patient’s characteristics are summarized in Table 1. ER was 
conducted with curative intent in all the patients enrolled. Mean 
age was 66.9±8.5 years (range, 45 to 82 years) and the patients 
were composed of 35 men (94.6%) and two women (5.4%) in 
this study. Mean tumor diameter was 11.5±5.5 mm (range, 3 to 
31 mm) with all histopathologically diagnosed as squamous cell 
carcinoma. The classification of macroscopic tumor morphology 
was that type 0-I was five lesion (13.5%); 0-IIa, four (10.8%); 
0-IIb, nine (24.3%); 0-IIc, 19 (51.4%); 0-III, 0 (0%), respectively. 
More than half of tumor location were middle esophagus (n=20, 
54.1%).
2. Clinical outcomes
The results of ER are shown in Table 2. Thirty-one lesions 
(83.8%) were treated by ESD, four lesions by EMR-P and two 
lesions by EMR-C. Median duration of ER was 56 minutes (range, 
10 to 180 minutes). Overall en bloc resection rate was 34 of 37 
(91.9%). Complete resection rate was 25 of 31 (80.6%) in ESD 
group and five of six (83.3%) in EMR group, and there was no 
Table 1. Patient and Tumor Characteristics (N=37)
Characteristic Value
Gender
   Male
   Female
Age, yr
Histology
   Squamous cell carcinoma
   Others
Tumor size, mm
Tumor location
   Upper esophagus
   Middle esophagus
   Lower esophagus
Dominant macroscopic subtype 
   0-I
   0-IIa
   0-IIb
   0-IIc
   0-III
Pre-existing comorbidity
   Cardiovascular disease
   Renal dysfunction
   Diabetes
   Other malignancy
35 (94.6)
2 (5.4)
66.9±8.5 (45–82)
37 (100)
0 
11.5±5.5 (3–31)
3 (8.1)
20 (54.1)
14 (37.8)
5 (13.5)
4 (10.8)
9 (24.3)
19 (51.4)
0 
22 (59.5)
1 (2.7)
6 (16.2)
8 (21.6)
Data are presented as number (%) or mean±SD (range).
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significant difference (p=0.421). In one case, two sessions ER 
was performed for 2 days because of large size and 75% cir-
cumferential extent of tumor in esophagus. The tumor invasion 
depth was diagnosed as epithelium, five (13.5%); lamina pro-
pria, 12 (32.4%); muscularis mucosa, 10 (27.0%); submucosa, 
10 (27.0%). The reason of incomplete resection of one patient in 
EMR group was the presence of high grade dysplasia on lateral 
margin of resected specimen. In ESD group, two patients were 
detected the presence of remnant carcinoma on vertical resec-
tion margin, two patients on lateral margin and two patients 
with positive lymphovascular invasion of carcinoma. One pa-
tient showed the presence of both lymphovascular invasion and 
carcinoma in lateral resection margin. In complication, there 
was no bleeding event, but perforations were developed in three 
lesions (8.1%) during ER. After ER, symptomatic esophageal 
strictures were found in two lesions (5.4%). 
3. Additional treatment after ER
Table 3 showed the results of ER and type of additional treat-
ments in the patients of diagnosed tumor invasion depth of 
epithelium and lamina propria group (n=17) and muscularis 
mucosa and submucosa group (n=20). In epithelium and lamina 
propria group, one patient was received additional treatment 
consisting of radiotherapy after ER because of vertical margin 
positive. 
In muscularis mucosa and submucosa group, 10 patients were 
treated ER followed by additional treatment and eight patients 
did not undergo further additional treatment and two patients 
were transferred to other hospital for follow-up examination by 
their demand. Among 10 patients of additional treatments, six 
patients underwent surgical resection of esophagectomy, three 
patients with radiotherapy, one patient with chemoradiotherapy. 
The chemoradiotherapy consisted of two cycles of cisplatin 80 
mg/m2 on days 2, and continuous infusion of 5-fluorouracil (5-
FU) 1,000 mg/m2/day on day 1 to 3, repeated every 4 weeks 
with concurrent radiotherapy of 50.4 Gy in 30 fractions. Among 
six esophagectomy group, the histopathologic assessment of 
Table 2. Results of Endoscopic Resection and Oncologic Outcomes 
(N=37)
Characteristic Value
Method of endoscopic resection 
   ESD
   EMR-P
   EMR-C
Type of resection
   En bloc resection
   Piecemeal resection
Complete resection rate
Subclassification of tumor depth
   Intraepithelium
   Lamina propria
   Muscularis mucosa
   Submucosa
Lymphovascular invasion
   Positive
   Negative
Lateral resection margin
   Positive
   Negative
Vertical resection margin 
   Positive
   Negative
Complication of endoscopic resection
   Bleeding
   Perforation
Stricture
Recurrence
Follow-up duration, mo
31 (83.8)
4 (10.8)
2 (5.4)
34 (91.9)
3 (8.1)
30 (81.1)
5 (13.5)
12 (32.4)
10 (27.0)
10 (27.0)
3 (8.1)*
34 (91.9)
3 (8.1)*
34 (91.9)
2 (5.4)
35 (94.6)
0 
3 (8.1)
2 (5.4)
0 
22 (4–79)
Data are presented as number (%) or median (range).
ESD, endoscopic submucosal dissection; EMR-P, endoscopic mucosal 
resection with precutting; EMR-C, endoscopic mucosal resection us-
ing a transparent cap procedure.
*In one case, both lateral resection margin and lymphovascular inva-
sion were positive. 
Table 3. Results of Endoscopic Resection and Additional Treatment 
Types in Tumor Invasion Depth of the Epithelial and Lamina Propria 
Group and Muscularis Mucosa and Submucosa Group 
Characteristic
Epithelium and 
lamina propria 
group (n=17)
Muscularis 
mucosa and 
submucosa 
group (n=20)
Endoscopic resection results
   Depth of tumor invasion
      Epithelium : Lamina propria
      Muscularis mucosa : Submucosa
   Vertical margin positive
   Lateral margin positive
   Lymphovascular invasion positive
Types of additional treatment
   Esophagectomy
   Chemotherapy
   Radiotherapy
   Chemoradiotherapy
   No additional treatment
   Transfer to other hospital
   Follow-up loss
5:12
  1 (5.8)
  0 
  0 
  0 
  0 
  1 (5.8)
  0 
13 (76.4)
  0 
  3 (17.6)
10:10
1 (5.0)
3 (15.0)*
3 (15.0)*
6 (30.0)†
0 
3 (15.0)
1 (5.0)
8 (40.0)
2 (10.0)
0 
Data are presented as number (%).
*In one case, both lateral resection margin and lymphovascular inva-
sion were positive; †In one case, esophagectomy followed by adjuvant 
chemotherapy was performed.
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surgically resected specimen showed that in five patients, no 
residual tumors were detected. In one patient, 1 mm size of 
epithelial high grade dysplasia was detected on lateral margin 
of ER. In regard of lymph node metastasis, two patients (2/6, 
33.3%) were diagnosed as the positive lymph node metastasis 
in which one patient had a metastatic right recurrent laryngeal 
lymph node and the other had a metastatic left infra-aortic 
lymph node. The patient with a metastatic right recurrent laryn-
geal lymph node received adjuvant chemotherapy composed of 
six cycles of cisplatin 80 mg/m2 on days 2, and continuous in-
fusion of 5-FU 1,000 mg/m2/day on day 1 to 3, repeated every 
4 weeks.
4. Survival
The median follow-up duration was 22 months (range, 4 to 
79 months). Synchronous or metachronous lesions of ESCC 
were not detected in all the patients, and local or metastatic 
recurrence and death did not occur during follow-up period. 
Clinical course of patients are represented in Fig. 1. 
DISCUSSION
Esophageal cancer has been treated by surgical resection, 
which is associated significant mortality that older than 65 
remained at 9%, 30% higher than any other major cancer op-
eration and postoperative morbidity.11,12 The rapid growth of 
the elderly population, severe concomitant diseases, reduced 
quality of life after esophagectomy and other primary malig-
nancy make the patients unable to be candidate for the surgical 
resection. This has led to other approaches to treat such as en-
doscopic treatment of esophageal cancer,13 and several studies 
had reported the results of ER in ESCC compared with surgical 
resection.14,15 ER has been recognized as the effective treatment 
for ESCC14,16 and recent prospective study was published evalu-
ating the efficacy and safety of ESD for superficial esophageal 
neoplasms.17 
EMR with various methods have been developed such as 
EMR-P and EMR-C, and disease-specific 5-year survival rate is 
exceeding 90% with a low complication rate.18 As ER come to 
be more and more advanced, the new method of ESD has be-
come offered as the standard methods of ER. ESD is superior to 
EMR as a curative treatment for early ESCC,19,20 and the risk of 
complications such as stenosis and perforation were not signifi-
cantly different.21 
ER in our study represents high en bloc resection rate and 
complete resection rate in superficial ESCC, and is comparable 
to other studies. The median diameter of lesion in ESD group 
was 12 mm (range, 3 to 31 mm) and 11 mm (range, 5 to 18 
mm) in EMR group (p=0.941). EMR was comparable in achiev-
ing complete resection in our study because of relatively smaller 
diameters of tumor by selection bias. Among seven patients of 
incomplete resection, four patients underwent esophagectomy, 
one patient received radiotherapy because of severe concomi-
tant disease, one patient refused additional treatment, and one 
patient was transferred to other hospital.
Regarding ER-related complications, perforations were de-
tected in three patients (8.1%) during ER. All case of perforation 
during endoscopic treatment could be treated by complete en-
doscopic closure with endoclips. And the patients were success-
fully managed by conservative cares, which included antibiotics 
and fluid replacement. The strictures were observed in two pa-
tients (5.4%) defined as narrowing that did not allow passage of 
conventional endoscope in symptomatic patients. All strictures 
were treated by repeated endoscopic balloon dilation and were 
managed successfully. No major and serious complications were 
detected in our study. 
ER might be the sufficient treatment option for the lesion as 
that do not infiltrate beyond the mucosa. In contrast, there is no 
standard clinical guideline about additional treatment after ER 
for muscularis mucosal and submucosal invading tumor with 
a high chance of lymph node metastasis. The additional treat-
ments included esophagectomy, chemotherapy, radiotherapy, 
and chemoradiotherapy.22 We generally recommended esopha-
gectomy as a salvage treatment to patients who were submuco-
sa invasion, incomplete resection of ER and had especially high 
risk of lymph node metastasis in muscularis mucosa invasion. 
But, for the reason of significant surgical mortality and morbid-
ity, if patients were unsuitable because of advanced age, severe 
Fig. 1. Clinical course of endoscopic 
resection patients of superficial eso-
phageal squamous cell carcinoma. 
ESCC, esophageal squamous cell 
carcinoma. *In one case, esophagec-
tomy followed by adjuvant chemo-
therapy was performed.
37 Endoscopic resection for superficial ESCC
17 Tumor invasion :
Epithelium, Lamina propria
20 Tumor invasion:
Muscularis mucosa, Submucosa
1 Rediotherapy 13 No additional
treatment
14 No recurred 3 Follow-up loss 18 No recurred
2 Transfer to
other hospital
6 Surgical
resection
4 Chemotherapy
and/or
radiotherapy
8 No
additional
treatment
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concomitant disease, and patients’ desire, alternative treatments 
were performed for such patients. 
In our study, among 10 patients of tumor invasion reaching 
submucosa, five patients received esophagectomy, three patients 
by radiotherapy, one patient by chemoradiotherapy respectively. 
And one patient was transferred to other hospital. This patient 
was planned to receive esophagectomy due to vertical margin 
positive, but transferred because of patient’s demand. In three 
patients of radiotherapy, external beam radiation dose was 50.4 
Gy in one patients and 54 Gy in two patients. One patient was 
treated by concurrent chemoradiotherapy without the specific 
severe complication. The reasons of additional treatment were 
that five patients were due to invasive tumor depth to submu-
cosa, three patients were positive resection margin, one patient 
was lymphovascular invasion, and one patient was both. All 
patients in tumor depth of invasion into submucosa group were 
followed up without local recurrence or metastasis.
In 10 patients of muscularis mucosa group, one patient un-
derwent surgical resection due to positive lateral margin of 
resected specimen. This patient had a metastatic right recurrent 
laryngeal lymph node and received adjuvant chemotherapy. All 
patients in muscularis mucosa group were followed up without 
local recurrence or metastasis except one patient being trans-
ferred to other hospital. This patient was complete resection of 
ER and in consultation about additional treatment. 
Among 17 patients of epithelium and lamina propria group, 
only one patient had an additional treatment that was composed 
of radiotherapy with fractionated 54 Gy by the reason of verti-
cal margin positive. This patient had several severe concomitant 
diseases and was at advanced age. All patients in epithelium 
and lamina propria group was maintained contact except three 
patients who were complete resection state and had become lost 
during follow-up.
In our study, additional treatments such as esophagectomy, 
radiotherapy, chemoradiotherapy were offered to the patients 
with deeper tumor invasion beyond the mucosa. Several studies 
showed that the metastatic rate was correlated significantly with 
the depth of tumor invasion.9,23 Clinically, the exact diagnosing 
the depth of tumor invasion before the treatment is still limited 
with low accuracy. The careful examination of the neoplasm 
namely macroscopic type of lesion and chromoendoscopy with 
lugol solution are the most important part of predicting tumor 
invasion depth and to find out of synchronous lesions. In ad-
dition, conventional EUS is necessary to evaluate accurate 
diagnosis of invasion depth and local lymph node metastasis. 
Conventional EUS was performed in 34 patients to evaluate the 
depth of invasion and presence of abnormal or enlarged lymph 
nodes in our study. The accuracy of T staging for distinguishing 
between mucosa and submucosa was 58.8%. Underdiagnosis 
rate was 26.5% (nine patients) and overdiagnosis rate 14.7% 
(five patients) by EUS. Several studies showed an accuracy in 
diagnosing submucosal invasion ranges from 33% to 85%.13,24-26 
On the basis of our data, it is proposed that before ER, accurate 
diagnosing the depth of tumor invasion and lymph node me-
tastasis are essential by macroscopic type of lesion and conven-
tional EUS to candidate for ER of superficial ESCC. Because en-
doscopic view is particularly limited in mucosal and submucosal 
carcinoma, the histopathologic assessment of endoscopically 
resected specimens is indispensable and is the principal determi-
nant for decision of additional treatment after ER.
Up to now, esophagectomy with lymph node dissection is 
the mainstay treatment after ER in incomplete ER or invasive 
tumor depth because of the risk of local recurrence and lymph 
node metastasis. But, esophagectomy is associated with the in-
creased mortality, high surgical risk and reduces the quality of 
life. Patient’s age, performance status, and various concomitant 
diseases should be concerned for offering an appropriate addi-
tional treatment. Long-term survival of early esophageal cancer 
is improving by degrees, thus, quality of life is the decisive fac-
tor as well. Radiotherapy and/or chemotherapy are possible to 
be a valid alternative treatment with similar oncologic outcomes 
to surgical resection and the effective modalities with less com-
plication than surgical resection. Therefore the choice of the ap-
propriate additional treatment is quite important for patient ac-
cording to tumor invasion depth of ESCC for this reason. In the 
current study, the data showed the excellent oncologic outcomes 
in tumor invasion depth of muscularis mucosa and submucosa 
regardless of additional treatment in addition to mucosal layer. 
Accordingly more effective multidisciplinary treatment strategy, 
the efficacy and usefulness of additional treatment after ER to 
be supported by well-designed studies is needed certainly. It is 
difficult to plan, but a randomized controlled study should be 
performed to evaluate the role of additional treatments. 
This study has several limitations such as relatively small size 
of tumor and sample size, single center study, comparatively 
short follow-up duration, and retrospective design. Neverthe-
less, the results of our study represent the first outcomes of 
endoscopic treatment and proposal of the additional treatment 
strategy after ER in a group of superficial ESCC with a relating 
adequate mean follow-up duration of 24.9 months (range, 4 to 
79 months) in South Korea. And the data represent the excel-
lent oncologic and clinical results by endoscopic treatment 
strategy in superficial ESCC. In conclusion, ER with appropriate 
additional treatment can be considered as an effective and rea-
sonable option, and tailored management after ER can offer an 
acceptable oncologic outcome in early ESCC.
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